New lens offers hope for clearer vision in cataract patients with keratoconus

NCT ID NCT07338708

Completed Disease control Sponsor: Azienda Ospedaliera Universitaria Integrata Verona Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special intraocular lens (Vivity EDOF) in 10 adults who had cataracts and mild keratoconus, a condition that thins and bulges the cornea. All participants received the lens in both eyes during standard cataract surgery. The goal was to see if the lens could provide good distance, intermediate, and near vision while maintaining safety and quality of life. Participants were followed for 3 months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Extended Depth of Focus Intraocular Lens (AcrySof IQ Vivity)
What this could lead to: If successful, this lens could offer a safe option for people with both cataracts and mild keratoconus to see clearly at multiple distances without glasses.
What could go wrong: This was a very small study (10 people) with no comparison group, so results may not apply to everyone. Mild keratoconus can progress, and the lens may not work as well in more advanced cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract keratoconus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT KERATOCONIC SUBJECTS

Contacts and locations

Locations

Azienda Ospedaliera Integrata di Verona

Verona, Verona, 37134, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.